Carbocal D 400
Natural health product licensed in Canada
- Other names
- Euro-Cal D 400
- Licence holder
- Euro-Pharm International Canada Inc.
- NPN or DIN-HM
- 80002899
- Status
- Inactive licence
- Licence date
- 1 March 2007
- Revision date
- 31 October 2011
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Calcium Source : Carbonate de calcium | 500 mg | Not calculated |
Non-medicinal ingredients
Laque d'aluminium-carmin d'indigo, Maltodextrine, Poly(éthylène glycol) 3350, triglycérides à chaînes moyennes, Sucrose, Béhénate de glycéryle, Croscarmellose de sodium, Cellulose, microcristalline, Talc, dl-alpha tocophérol, Poly(alcool vinylique), Modified food starch, Dioxyde de titanium, ascorbate de sodium, Silicon dioxide colloïdal, gomme acacia
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Comprimé ; maximum: 2 Comprimé | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Vitamin/ Mineral supplement. A factor in the maintenance of good health. Vitamin D helps in the development and maintenance of bones and teeth and in the absorption and use of calcium and phosphorous. Calcium helps in the development and maintenance of bones and teeth. Calcium intake, when combined with sufficient Vitamin D, a healthy diet and regular exercise may reduce the risk of developing osteoporosis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Avoid using two (2) hours prior to or until four (4) hours after taking other medications.
Source
Official Health Canada record, licence 80002899
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2011. Photograph the packaging to check whether it has changed. Photograph the packaging